Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glutalor Medical is a medical technology company specializing in the development and commercialization of advanced Continuous Glucose Monitoring (CGM) systems for diabetes management. The company's flagship products utilize proprietary enzyme-based electrochemical sensor technology to provide real-time glucose readings, helping patients and healthcare providers monitor glycemic levels more effectively. Headquartered in the United States with significant operations in China, Glutalor focuses on delivering affordable and accurate iCGM solutions. Their devices are designed for ease of use, featuring long-wear sensors and wireless data transmission to mobile applications. The company aims to improve the quality of life for individuals with diabetes through continuous, minimally invasive monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glutalor Medical.